Sian Davies
About Sian Davies
Sian Davies is a Senior Scientist specializing in MSAT Process Development at MeiraGTx, where she has worked since 2020. She holds a Master's degree in Biochemical Engineering from UCL and has prior experience as a Downstream Process Scientist at Ipsen.
Work at MeiraGTx
Sian Davies has been employed at MeiraGTx since 2020. Initially serving as a Downstream Process Development Scientist, she transitioned to the role of MSAT Process Development Senior Scientist I in 2023. Her work focuses on the development and optimization of manufacturing processes, contributing to the advancement of gene therapies. MeiraGTx is known for its innovative approaches in the field of gene therapy, and Davies plays a key role in ensuring the efficiency and effectiveness of these processes.
Education and Expertise
Sian Davies studied Biochemical Engineering at University College London (UCL), where she earned her Master's degree from 2017 to 2018. This educational background has equipped her with a strong foundation in biochemical processes and engineering principles, which she applies in her current roles. Her expertise lies in downstream process development, where she focuses on refining and enhancing manufacturing techniques in the biopharmaceutical sector.
Background
Before joining MeiraGTx, Sian Davies worked at Ipsen as a Downstream Process Scientist from 2018 to 2020. In this role, she was involved in various aspects of process development, contributing to the production of biopharmaceutical products. Her experience at Ipsen provided her with valuable insights and skills that she has carried into her current position at MeiraGTx.
Professional Experience
Sian Davies has accumulated significant experience in the biopharmaceutical industry over the past several years. Her roles have included positions focused on downstream process development, where she has worked on optimizing processes to enhance product yield and quality. This experience has positioned her as a knowledgeable professional in the field, particularly in the context of gene therapy development.